AtriCure director's trust proposes $143K share sale
AtriCure, Inc. (ATRC) common shares are listed for a proposed sale for the account of B Kristine Johnson Declaration Trust: 2,452 shares with an aggregate market value of $143,397.13.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AtriCure, Inc. (ATRC) common shares are listed for a proposed sale for the account of B Kristine Johnson Declaration Trust: 2,452 shares with an aggregate market value of $143,397.13. The notice lists November 6, 2026 as the approximate sale date and Morgan Stanley Smith Barney LLC as broker. Beth Kristine Johnson signed as trustee; the notice identifies her as a director. The shares are described as acquired through restricted stock vesting under a registered plan on May 20, 2021.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock vesting financial
registered plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What broker and sale date are listed for the proposed ATRC sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.